Meetings

July 7-10, 2026 | Geneva

Dr. Alex Aliper, Co-founder and President of Insilico Medicine, will attend the AI for Good Global Summit 2026 in Geneva, Switzerland, on July 7.

July 8, 2026 | Beijing

Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the CITICS Global Consumer and Healthcare Forum 2026 in Beijing on July 8.

July 8-10, 2026 | Hong Kong

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend the international science, technology, and information technology exhibition, LEAP EAST, held in Hong Kong from July 8 to 10.

Conference Announcement: 2026 International Symposium on Energy Frontiers

We are pleased to announce that the International Conference on Advanced (Nano)composites 2027 (ICAN 2027 Adelaide) will be held from 1–4 February 2027 at Adelaide University, Australia.

With the Lecture Series on Cancer Breakthroughs, Gustave Roussy and The Lancet are joining forces to create a high-level annual international event dedicated to major scientific advances that are transforming—or will transform—the lives of patients at increased risk of cancer or living with the disease. These lectures aim to accelerate the dissemination of innovation and the sharing of knowledge for the benefit of patients worldwide. The inaugural lecture, to be held on 18 September in France and online, will focus on personalised cancer prevention. This first Lecture will be chaired by a distinguished guest, Professor Timothy R. Rebbeck, Professor at the Harvard T.H. Chan School of Public Health and the Dana-Farber Cancer Institute.

CIMMYT and its partners convened the Harvesting the Future Africa Summit in Nairobi to accelerate investment in science-driven agricultural solutions for Africa. Bringing together leaders from government, research, finance, philanthropy, and the private sector, the summit focused on scaling proven innovations that strengthen food security, resilience, and economic opportunity. The event concluded with a call for stronger investment and collaboration to transform Africa’s food systems at scale.

The ANERIS project has held its Final Consortium Meeting in person, bringing together all project partners for a two-day progress gathering.

At the BIO International Convention 2026, clinical-stage generative AI drug discovery company Insilico Medicine announced a record-breaking $2.5 billion global R&D collaboration with SK Biopharmaceuticals to develop central nervous system treatments, alongside driving extensive thought leadership across five featured presentations.

At the BIO International Convention 2026, clinical-stage generative AI drug discovery company Insilico Medicine announced a record-breaking $2.5 billion global R&D collaboration with SK Biopharmaceuticals to develop central nervous system treatments, alongside driving extensive thought leadership across five featured presentations.

SpongeBoost is organising an online webinar exploring how evidence can be transformed into action for sponge landscapes through a showcase of the project’s outputs.